Stock listing

Shanghai:688192 Dizal (Jiangsu) Pharmaceutical Co. Ltd. (迪哲医药) 股价

Follow Dizal (Jiangsu) Pharmaceutical Co. Ltd. into a list and get an email when it puts out news.

Share price · SSE:688192

¥61.40 CNY -1.80 (-2.8%)

Close on Oct 20, 2026

Past year -2.2% · daily closes, Oct 20, 2025 – Oct 20, 2026, adjusted for splits
Day range
¥60.11 – ¥62.75 CNYOct 20, 2026
Volume
5.66M sharesOct 20, 2026
Market cap
¥28.56B CNYAt the close on Oct 20, 2026 · price × 465.2M shares outstanding
52-week range
¥35.73 – ¥71.26 CNYLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Dizal (Jiangsu) Pharmaceutical Co. Ltd. logo

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · SSE:688192 · CNY, adjusted for splits

DayCloseChange%OpenHighLowVolume
¥61.40-1.80-2.8%¥62.00¥62.75¥60.115,662,106
¥63.20+0.60+1.0%¥62.03¥63.98¥60.186,333,617
¥62.60+2.94+4.9%¥60.86¥65.30¥60.869,155,917
¥59.66-1.03-1.7%¥59.18¥61.18¥58.824,765,733
¥60.69-1.21-2.0%¥61.74¥62.50¥60.625,683,360
¥61.90+4.46+7.8%¥56.60¥62.00¥56.049,367,699
¥57.44-2.51-4.2%¥59.88¥60.17¥57.444,604,602
¥59.95+1.65+2.8%¥57.32¥61.50¥56.217,897,133
¥58.30+0.29+0.5%¥58.59¥60.21¥56.508,117,035
¥58.01+2.19+3.9%¥57.30¥60.00¥55.578,285,178
¥55.82+0.34+0.6%¥55.60¥57.50¥54.704,118,001
¥55.48-0.97-1.7%¥56.28¥56.75¥55.153,202,157
¥56.45-3.80-6.3%¥59.95¥61.27¥56.026,515,172
¥60.25-1.11-1.8%¥61.28¥61.50¥60.074,432,814
¥61.36+0.97+1.6%¥60.00¥62.00¥59.445,385,848
¥60.39+2.94+5.1%¥57.97¥61.97¥57.406,887,471
¥57.45+0.66+1.2%¥57.20¥58.48¥56.853,355,829
¥56.79+1.05+1.9%¥55.75¥57.99¥55.533,829,055
¥55.74+0.20+0.4%¥55.10¥56.50¥55.103,526,857
¥55.54+0.75+1.4%¥54.64¥55.60¥54.113,375,841
¥54.79+1.72+3.2%¥52.53¥55.88¥52.084,400,677
¥53.07-1.31-2.4%¥54.05¥54.43¥52.323,886,961
¥54.38-0.52-0.9%¥54.92¥55.45¥53.713,274,113
¥54.90-1.54-2.7%¥56.23¥56.43¥54.904,448,735
¥56.44-0.20-0.4%¥56.50¥57.58¥55.444,199,383
¥56.64-0.43-0.8%¥56.72¥57.85¥56.243,899,959
¥57.07-3.01-5.0%¥58.65¥59.79¥56.189,006,463
¥60.08+2.74+4.8%¥57.82¥60.69¥57.066,503,221
¥57.34-0.51-0.9%¥57.86¥58.77¥57.224,415,153
¥57.85-0.43-0.7%¥59.48¥59.88¥57.044,031,031
¥58.28-0.39-0.7%¥57.87¥59.58¥57.506,075,673
¥58.67+0.12+0.2%¥58.50¥59.00¥57.724,078,184
¥58.55+0.76+1.3%¥57.56¥58.75¥56.616,259,817
¥57.79-2.41-4.0%¥59.90¥61.87¥57.576,545,654
¥60.20+1.03+1.7%¥59.00¥61.68¥58.227,665,271
¥59.17+0.17+0.3%¥59.74¥60.50¥57.628,387,598
¥59.00-3.15-5.1%¥60.45¥61.10¥58.109,050,663
¥62.15+3.15+5.3%¥61.49¥62.32¥59.2811,309,684
¥59.00-2.24-3.7%¥60.10¥61.77¥58.596,815,515
¥61.24-0.09-0.1%¥61.38¥62.65¥59.937,164,980
¥61.33+0.42+0.7%¥60.01¥62.45¥59.587,425,687
¥60.91-0.28-0.5%¥60.99¥62.49¥59.209,258,784
¥61.19+2.40+4.1%¥57.52¥63.66¥57.5213,535,806
¥58.79+0.71+1.2%¥57.51¥61.20¥57.1111,268,935
¥58.08+2.23+4.0%¥54.79¥61.49¥54.7914,458,362
¥55.85-0.15-0.3%¥56.99¥58.58¥54.7212,523,217
¥56.00+3.56+6.8%¥52.50¥56.00¥52.2011,997,581
¥52.44-0.59-1.1%¥53.81¥54.30¥51.608,266,352
¥53.03+2.77+5.5%¥49.98¥54.33¥49.9812,921,908
¥50.26+0.83+1.7%¥50.40¥51.90¥49.789,040,465
¥49.43-1.62-3.2%¥51.07¥51.50¥48.319,660,103
¥51.05-0.11-0.2%¥52.00¥52.68¥50.787,842,355
¥51.16-2.17-4.1%¥52.70¥53.46¥50.638,216,683
¥53.33-0.27-0.5%¥53.05¥54.98¥52.409,270,888
¥53.60-3.01-5.3%¥55.98¥56.50¥53.2310,187,753
¥56.61+1.01+1.8%¥54.50¥57.30¥53.9510,330,203
¥55.60-2.74-4.7%¥57.02¥58.88¥55.4713,497,445
¥58.34-2.52-4.1%¥60.46¥61.10¥58.1115,027,800
¥60.86-0.92-1.5%¥60.10¥65.90¥60.1018,270,835
¥61.78-1.10-1.7%¥60.76¥61.80¥56.7820,804,670
¥62.88+1.46+2.4%¥58.01¥64.76¥58.0118,395,038
Ticker
Shanghai:688192
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Shanghai
Currency
CNY

What changed lately

Latest news

(688192)"DIZAL PHARMACEUTICAL CO., LTD."Indicative Announcement on Change in Equity Interests of Shareholder Holding More Than 5% of the Shares and Its Persons Acting in Concert Reaching an Integer Multiple of 5% Threshold and Disclosure of Simplified Report on Change in Equity Interests

Oct 20, 2026

Closed ¥61.40 (-2.8%) on Oct 20, 2026

(688192)"DIZAL PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of Receipt of a USD 600 Million Upfront Payment from AstraZeneca for the Global Licensing of ZEGFROVY

Sep 30, 2026

Closed ¥58.01 (+3.9%) on Sep 30, 2026

Announcement on Use of Temporarily Idle Self-owned Funds for Entrusted Wealth Management

Sep 30, 2026

Closed ¥58.01 (+3.9%) on Sep 30, 2026

Announcement on Shareholding Reduction Plan of Senior Executive

Sep 25, 2026

Closed ¥55.48 (-1.7%) on Sep 28, 2026

Announcement on Voluntary Disclosure of Publication of Research Results on Birelentinib for the Treatment of Diffuse Large B-Cell Lymphoma in "Blood Cancer Journal"

Sep 10, 2026

Closed ¥54.38 (-0.9%) on Sep 10, 2026

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the Innovative Drug Industry

Sep 9, 2026

Closed ¥54.90 (-2.7%) on Sep 9, 2026

Announcement on Shareholding Reduction Plan of Directors and Senior Management

Sep 4, 2026

Closed ¥57.07 (-5.0%) on Sep 4, 2026

Announcement on Voluntary Disclosure of the Acceptance by the U.S. FDA of the Supplemental New Drug Application for Sunvozertinib as a Monotherapy for the First-Line Treatment of Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Aug 31, 2026

Closed ¥58.28 (-0.7%) on Aug 31, 2026

Dizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026

Aug 21, 2026

Closed ¥59.17 (+0.3%) on Aug 24, 2026

Announcement on Resolutions of the 1st Meeting of the 3rd Board of Directors

Aug 21, 2026

Closed ¥59.00 (-5.1%) on Aug 21, 2026

All Dizal (Jiangsu) Pharmaceutical Co. Ltd. news

Decks

Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
49 in the last 12 months · 80 in all · newest Oct 20, 2026 · oldest 2025
Decks
1 deck · latest Jan 15, 2026

Log in to ask 6ix AI your own questions about Dizal (Jiangsu) Pharmaceutical Co. Ltd.